オランダの関節リウマチ患者におけるJAK阻害薬またはbDMARDs治療と心血管イベントリスク
Rheumatology (Oxford) 2023 doi 10.1093/rheumatology/kead531 Epub ahead of print
This retrospective inception cohort study investigated RA patients starting a new bDMARD or JAKi prescription between 01 August 2018 and 31 January 2022 from IQVIA’s Dutch Real-World Data Longitudinal Prescription database.